Mackenzie Financial Corp Seagen Inc. Transaction History

Mackenzie Financial Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$191.51 - $216.16 $48,643 - $54,904	-254 Reduced 3.25%	7,557 $1.6 Million
Q2 2023 Aug 03, 2023	SELL	$187.64 - $206.25 $3.85 Million - $4.23 Million	-20,506 Reduced 72.42%	7,811 $1.5 Million
Q1 2023 Apr 24, 2023	SELL	$127.59 - $203.08 $743,339 - $1.18 Million	-5,826 Reduced 17.06%	28,317 $5.73 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $1.8 Million - $2.14 Million	-15,359 Reduced 31.03%	34,143 $4.39 Million
Q3 2022 Oct 07, 2022	SELL	$135.27 - $180.11 $2.12 Million - $2.82 Million	-15,677 Reduced 24.05%	49,502 $6.77 Million

Q2 2022 Aug 10, 2022	BUY	$108.81 - $179.33 $36,342 - $59,896	334 Added 0.52%	65,179 $11.5 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $2.65 Million - $3.5 Million	-22,169 Reduced 25.48%	64,845 $9.34 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $283,856 - $380,002	1,991 Added 2.34%	87,014 $13.5 Million
Q3 2021 Nov 08, 2021	BUY	$142.45 - $169.82 $602,136 - $717,829	4,227 Added 5.23%	85,023 $14.4 Million
Q2 2021 Aug 11, 2021	BUY	$135.08 - $161.1 $1.22 Million - $1.45 Million	9,017 Added 12.56%	80,796 $12.8 Million
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $7.54 Million - $10.5 Million	54,812 Added 323.05%	71,779 $9.97 Million
Q4 2020 Feb 10, 2021	BUY	$164.63 - $211.93 $2.79 Million - $3.6 Million	16,967 New	16,967 $2.97 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.